Viewing Study NCT01837667


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-01-01 @ 7:01 AM
Study NCT ID: NCT01837667
Status: COMPLETED
Last Update Posted: 2017-01-24
First Post: 2013-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of LB-100 With Docetaxel in Solid Tumors
Sponsor: Lixte Biotechnology Holdings, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module